Facebook Twitter LinkedIn Instagram Email Printer Google Plus

John Rudoy, PhD

Principal, Health & Life Sciences, Oliver Wyman

A Guide to Economic Recovery for Health System CFOs

How prioritizing long-term organizational changes immediately will ensure stability post-crisis.

Partner, Health & Life Sciences, Oliver Wyman
Partner and Chief Medical Officer, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Global Head, Provider, Health and Life Sciences, Oliver Wyman

It’s senior leadership’s job — including board members — to mitigate the effects of this pandemic.

Partner, Health & Life Sciences, Oliver Wyman
Partner and Chief Medical Officer, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Specialty drugs represent an opportunity to better serve patients, but also pose risks.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Actuarial, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Men hold most (87 percent) of C-suite roles at healthcare’s top ranks. But why?

Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

They Just Have to Persuade People to Like Them

Oliver Wyman research examines whether consumers are using healthcare’s “new front door”, and if not, why not.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Oliver Wyman's 2018 Consumer Survey explores healthcare's supply and demand disconnect.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Former Partner, Health & Life Sciences, Oliver Wyman

Women, healthcare's primary consumers, are 20 percent more likely than men are to express frustrations with the healthcare system.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Some of our 2018 predictions on consolidation, pharma, and investment came true, while others were less predictable.

Principal, Health & Life Sciences, Oliver Wyman

As merger activity heightens, some leverage retail with pharma to meet consumer demand.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

How pharmaceutical companies can better define, measure, and deliver value to patients.

Principal, Health & Life Sciences, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe